Dissertation2019
Identification of mechanisms of gemcitabine resistance using a whole genome shRNA screen in a novel in vitro coculture model of pancreatic cancer
- Published
- 1 January 2019
- Citations
- 0
- Type
- Dissertation
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most difficult to treat major cancers, with a 5-year survival of less than 5%, and little to no improvement in prognosis over the previous fifty years. The complexity and heterogeneity of the pancreatic tumour and its highly desmoplastic stromal microenvironment present major physical and biochemical barriers to the delivery and efficacy of therapeutics. … Excerpt only: this text is the publisher’s. Read it in full at the source.